Chan Wang1, Zonglan Xie2, Chuanjiang Dong1* and Ziqiang Dong1
1Departments of Urology, The First College of Clinical Medical Science, China Three Gorges University, Yichang Central People’s Hospital, China
2Departments of Nephrology, The First College of Clinical Medical Science, China Three Gorges University, Yichang Central People’s Hospital, China
Objective: To evaluate the safety and effectiveness of reverse suture technique during RLPN for dorsal lower pole renal tumors. Methods: A retrospective analysis of the clinical data of all patients with dorsal lower pole renal tumors underwent RLPN using reverse suture technique in our hospital from March 2015 to March 2020. All surgeries involved the reverse suture technique, following the same procedure: Reveal and block the renal artery with an artery clamp, completely remove the tumor, defects of the vascular and collecting system were repaired and the continuous reverse suture technique was used for suture of renal parenchyma. Variable analysis included operative time, blood loss, and warm ischemia time, and positive margin rate, length of hospitalization and perioperative complications. Results: Among the 11 patients, 6 were male and 5 were female. The average age was 56.8 ± 6.8 years old. The tumor diameter was 3.4 ± 0.6 cm. The warm ischemic time was 28.1 ± 5.8 min. All surgeries were successful without conversion to radical nephrectomy or open partial nephrectomy. The average estimated blood loss was 116.4 ± 29.1 ml. The mean operative time was 124.9 ± 28.5 min, the drain removal time was 4.4 ± 1.4 days, the average length of hospitalization was 8.3 ± 1.6 days, and all patients recovered well after the operation without major complications. Conclusion: The reverse suture technique is safe and effective for management of dorsal lower pole renal tumors during RLPN for selected patients.
Nephron-sparing surgery; Laparoscopic partial nephrectomy; Renal tumor
Wang C, Xie Z, Dong C, Dong Z. Reverse Suture Technique in Retroperitoneal Laparoscopic Partial Nephrectomy for Dorsal Lower Pole Renal Tumors. Clin Surg. 2022; 7: 3425.